References
- March WA, Moore VM, Wilson K, et al. The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum Reprod 2010;25:544–51.
- Nestler JE. Role of hyperinsulinemia in the pathogenesis of the polycystic ovary syndrome, and its clinical implications. Semin Reprod Endocrinol 1997; 15:111–22.
- Apridonidze T, Essah PA, Iuorno MJ, Nestler JE. Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome. J Clin Endocrinol Metab 2005;90:1929–35.
- Armanini D, Bordin L, Donà G, et al. Polycystic ovary syndrome: implications of measurement of plasma aldosterone, renin activity and progesterone. Steroids 2012;77:655–8.
- Murri M, Luque-Ramírez M, Insenser M, et al. Circulating markers of oxidative stress and polycystic ovary syndrome (PCOS): a systematic review and meta-analysis. Hum Reprod Update 2013;19:268–88.
- Piomboni P, Focarelli R, Capaldo A, et al. Protein modification as oxidative stress marker in follicular fluid from women with polycystic ovary syndrome: the effect of inositol and metformin. J Assist Reprod Genet 2014;31:1269–76.
- Orio F Jr, Palomba S, Spinelli L, et al. The cardiovascular risk of young women with polycystic ovary syndrome: an observational, analytical, prospective case-control study. J Clin Endocrinol Metab 2004;89:3696–701.
- Krstić J, Trivanović D, Mojsilović S, Santibanez JF. Transforming growth factor-beta and oxidative stress interplay: implications in tumorigenesis and cancer progression. Oxid Med Cell Longev 2015;2015:654–594.
- Ziech D, Franco R, Pappa A, Panayiotidis MI. Reactive oxygen species (ROS)-induced genetic and epigenetic alterations in human carcinogenesis. Mutat Res 2011;711:167–73.
- Stadtman ER, Levine RL. Protein oxidation. Ann N Y Acad Sci 2000;899:191–208.
- Bordin L, Fiore C, Bragadin M, et al. Regulation of membrane band 3 Tyr-phosphorylation by proteolysis of p72(Syk) and possible involvement in senescence process. Acta Biochim Biophys Sin (Shanghai) 2009;41:846–51.
- Bordin L, Quartesan S, Zen F, et al. Band 3 Tyr-phosphorylation in human erythrocytes from non-pregnant and pregnant women. Biochim Biophys Acta 2006;1758:611–9.
- Bordin L, Donà G, Sabbadin C, et al. Human red blood cells alterations in primary aldosteronism. J Clin Endocrinol Metab 2013;98:2494–501.
- Donà G, Sabbadin C, Fiore C, et al. Inositol administration reduces oxidative stress in erythrocytes of patients with polycystic ovary syndrome. Eur J Endocrinol 2012;166:703–10.
- Bordin L, Fiore C, Zen F, et al. Dapsone hydroxylamine induces premature removal of human erythrocytes by membrane reorganization and antibody binding. Br J Pharmacol 2010;161:1186–99.
- Bordin L, Ion-Popa F, Brunati AM, et al. Effector-induced Syk-mediated phosphorylation in human erythrocytes. Biochim Biophys Acta 2005;1745:20–8.
- Andrisani A, Donà G, Brunati AM, et al. Increased oxidation-related glutathionylation and carbonic anhydrase activity in endometriosis. Reprod Biomed Online 2014;28:773–9.
- Andrisani A, Donà G, Sabbadin C, et al. Dapsone hydroxylamine-mediated alterations in human red blood cells from endometriotic patients. Gynecol Endocrinol 2017;30:1–5.
- Bordin L, Fiore C, Donà G, et al. Evaluation of erythrocyte band 3 phosphotyrosine level, glutathione content, CA-125, and human epididymal secretory protein E4 as combined parameters in endometriosis. Fertil Steril 2010;94:1616–21.
- Zonta F, Pagano MA, Trentin L, et al. Lyn-mediated procaspase 8 dimerization blocks apoptotic signaling in B-cell chronic lymphocytic leukemia. Blood 2014;123:875–83.
- Tibaldi E, Venerando A, Zonta F, et al. Interaction between the SH3 domain of Src family kinases and the proline-rich motif of HTLV-1 p13: a novel mechanism underlying delivery of Src family kinases to mitochondria. Biochem J 2011;439:505–16.
- Bragadin M, Ion-Popa F, Clari G, Bordin L. SHP-1 tyrosine phosphatase in human erythrocytes. Ann N Y Acad Sci 2007;1095:193–203.
- Genazzani AD. Inositol as putative integrative treatment for PCOS. Reprod Biomed Online 2016; 33:770–80.
- The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004;81:19–25.
- Bordin L, Brunati AM, Donella-Deana A, et al. Band 3 is an anchor protein and a target for SHP-2 tyrosine phosphatase in human erythrocytes. Blood 2002;100:276–82.
- Arese P, Turrini F, Schwarzer E. Band 3/complement-mediated recognition and removal of normally senescent and pathological human erythrocytes. Cell Physiol Biochem 2005;16:133–46.
- Lutz HU. Naturally occurring anti-band 3 antibodies in clearance of senescent and oxidatively stressed human red blood cells. Transfus Med Hemother 2012;39:321–7.
- Allan D. Inositol lipids and membrane function in erythrocytes. Cell Calcium 1982;3:4514–65.
- Piatti E, Piacentini MP, Fraternale D, et al. myo-[3H]-inositol loaded erythrocytes and white ghosts: two models to investigate the phosphatidylinositol synthesis in human red cells. Biochimie 1999;81:1011–4.
- Kinoshita T. Biosynthesis and deficiencies of glycosylphosphatidylinositol. Proc Jpn Acad Ser B Phys Biol Sci 2014;90:130–43.